CAS RN 859212-16-1
IUPAC Namn:
N-[3-({[4,5'-bipyrimidin]-2-yl}amino)-4-methylphenyl]-4-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide
Synonymer:
N-(3-{[4,5'-bipyrimidin]-2-ylamino}-4-methylphenyl)-4-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide
Molekylvikt (g/mol):
576.63
Molekylär sammansättning:
C30H31F3N8O
InChi Key:
ZGBAJMQHJDFTQJ-UHFFFAOYNA-N
SMILES:
CN(C)C1CCN(CC2=C(C=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CN=C3)=C(C)C=C2)C(F)(F)F)C1
1
–
4
av
4
Resultat
2
Bafetinib, TRC
High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.
3
Bafetinib, TRC
High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.
4
Bafetinib, MedChemExpress
MedChemExpress Bafetinib is a potent and orally active Lyn/Bcr-Abl tyrosine kinase inhibitor. Bafetinib augments the activities of several proapoptotic Bcl-2 homology (BH)3-only proteins (Bim, Bad, Bmf and Bik) and induces apoptosis in Ph+ leukemia cells via Bcl-2 family-regulated intrinsic apoptosis pathway.
